Alignment Healthcare Inc (NASDAQ:ALHC) has a beta value of 1.43 and has seen 1.27 million shares traded in the last trading session. The company, currently valued at $2.30B, closed the last trade at $12.05 per share which meant it lost -$0.05 on the day or -0.41% during that session. The ALHC stock price is -18.26% off its 52-week high price of $14.25 and 62.99% above the 52-week low of $4.46. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.37 million shares traded. The 3-month trading volume is 1.69 million shares.
The consensus among analysts is that Alignment Healthcare Inc (ALHC) is Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 1 rate it as Overweight. 3 out of 10 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.09.
Alignment Healthcare Inc (NASDAQ:ALHC) trade information
Sporting -0.41% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ALHC stock price touched $12.05 or saw a rise of 2.82%. Year-to-date, Alignment Healthcare Inc shares have moved 39.95%, while the 5-day performance has seen it change 4.92%. Over the past 30 days, the shares of Alignment Healthcare Inc (NASDAQ:ALHC) have changed 13.25%. Short interest in the company has seen 4.51 million shares shorted with days to cover at 2.77.
Wall Street analysts have a consensus price target for the stock at $9.5, which means that the shares’ value could drop -26.84% from current levels. The projected low price target is $7.0 while the price target rests at a high of $12.0. In that case, then, we find that the current price level is 0.41% off the targeted high while a plunge would see the stock lose 41.91% from current levels.
Alignment Healthcare Inc (ALHC) estimates and forecasts
Figures show that Alignment Healthcare Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 68.30% over the past 6 months, with this year growth rate of 12.66%, compared to 4.30% for the industry. Revenue growth from the last financial year stood is estimated to be 46.81%.
9 analysts offering their estimates for the company have set an average revenue estimate of 675.47M for the current quarter. 7 have an estimated revenue figure of 846.8M for the next ending quarter. Year-ago sales stood 465.39M and 628.6M respectively for this quarter and the next, and analysts expect sales will grow by 45.14% for the current quarter and 46.81% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -35.06% over the past 5 years.
ALHC Dividends
Alignment Healthcare Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Alignment Healthcare Inc (NASDAQ:ALHC)’s Major holders
Insiders own 5.17% of the company shares, while shares held by institutions stand at 87.31% with a share float percentage of 92.07%. Investors are also buoyed by the number of investors in a company, with Alignment Healthcare Inc having a total of 194.0 institutions that hold shares in the company. The top two institutional holders are GENERAL ATLANTIC, L.P. with over 60.99 million shares worth more than $476.97 million. As of 2024-06-30, GENERAL ATLANTIC, L.P. held 32.2707% of shares outstanding.
The other major institutional holder is WARBURG PINCUS LLC, with the holding of over 17.92 million shares as of 2024-06-30. The firm’s total holdings are worth over $140.16 million and represent 9.4827% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Select Portfolios – Health Care and Fidelity Advisor Health Care Fund . As of Sep 30, 2024 , the former fund manager holds about 2.92% shares in the company for having 5.6 shares of worth $67.48 million while later fund manager owns 3.5 shares of worth $42.17 million as of Sep 30, 2024 , which makes it owner of about 1.83% of company’s outstanding stock.
